TY - JOUR
T1 - Effect of brief levodopa holidays on the short-duration response to levodopa
T2 - Evidence for tolerance to the antiparkinsonian effects
AU - Nutt, John G.
AU - Carter, Julie H.
AU - Woodward, William R.
PY - 1994/9
Y1 - 1994/9
N2 - To determine whether tolerance to the antiparkinsonian actions of levodopa develops during long-term levodopa therapy, we compared the response to 2-hour levodopa infusions before and after 2- to 4-day levodopa holidays using tapping and walking speeds and tremor/dyskinesia scores as measures of response in 17 parkinsonian patients with a fluctuating response to levodopa. As expected, motor function deteriorated during the levodopa holiday, but the maximum motor tapping and walking speeds and dyskinesia scores produced by the levodopa infusion before the holiday were the same as those produced by the infusion after the holiday. Because the baseline motor function was lower after the holiday, the increment in tapping and walking speeds (ie, the difference between the baseline and the maximum response) was larger with the postholiday infusion (p < 0.01). The postholiday infusion produced a longer response than did the preholiday infusion as measured by tapping score (p = 0.047), walking speed (p = 0.02), and tremor or dyskinesia scores (p = 0.02). The prolongation of the response was greater in patients receiving larger daily doses of levodopa (r = 0.55; p = 0.03). These changes in the duration of response suggest that progressive shortening of the response to levodopa during long-term therapy is partially caused by development of tolerance to levodopa and not just by loss of dopamine storage sites. Tolerance to levodopa should be considered in establishing oral dosing regimens and in developing new strategies for drug delivery.
AB - To determine whether tolerance to the antiparkinsonian actions of levodopa develops during long-term levodopa therapy, we compared the response to 2-hour levodopa infusions before and after 2- to 4-day levodopa holidays using tapping and walking speeds and tremor/dyskinesia scores as measures of response in 17 parkinsonian patients with a fluctuating response to levodopa. As expected, motor function deteriorated during the levodopa holiday, but the maximum motor tapping and walking speeds and dyskinesia scores produced by the levodopa infusion before the holiday were the same as those produced by the infusion after the holiday. Because the baseline motor function was lower after the holiday, the increment in tapping and walking speeds (ie, the difference between the baseline and the maximum response) was larger with the postholiday infusion (p < 0.01). The postholiday infusion produced a longer response than did the preholiday infusion as measured by tapping score (p = 0.047), walking speed (p = 0.02), and tremor or dyskinesia scores (p = 0.02). The prolongation of the response was greater in patients receiving larger daily doses of levodopa (r = 0.55; p = 0.03). These changes in the duration of response suggest that progressive shortening of the response to levodopa during long-term therapy is partially caused by development of tolerance to levodopa and not just by loss of dopamine storage sites. Tolerance to levodopa should be considered in establishing oral dosing regimens and in developing new strategies for drug delivery.
UR - http://www.scopus.com/inward/record.url?scp=0027982105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027982105&partnerID=8YFLogxK
U2 - 10.1212/wnl.44.9.1617
DO - 10.1212/wnl.44.9.1617
M3 - Article
C2 - 7936285
AN - SCOPUS:0027982105
SN - 0028-3878
VL - 44
SP - 1617
EP - 1622
JO - Neurology
JF - Neurology
IS - 9
ER -